PainBy Tom Steinert-Threlkeld | Posted 2003-05-01 Email Print
WEBINAR: On-demand webcast
Next-Generation Applications Require the Power and Performance of Next-Generation Workstations REGISTER >
Endo Pharmaceuticals started out small. But it acted from the beginning as if it would be a billion-dollar company.-Free in 2002">
Endo Pharmaceuticals: Pain-Free in 2002
Percocet manufacturer Endo Pharmaceuticals worried it might grow so fast, it installed SAP R/3 as its enterprise planning software, from its inception as an offshoot of a Dupont-Merck joint venture. Last year proved the case: The company raised its "guidance" on annual sales for the year three times. And its final estimate was still too low.
Final sales for the year: $399M
Projection raised one last time
Projection raised again, to $350M
Projection raised to $300M at start of Q2...
for full year:
BASELINE Company's guidance to market on expected sales for the year, before each quarter started.
ACTUAL Endo's sales, year to date.
Source: ENDO PHARMACEUTICALS